2hon MSN
Immune sabotage: How a vitamin A byproduct compromises the body's normal anti-cancer response
Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...
Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...
Medicine is a constantly evolving science where small changes can have a huge impact on the lives of patients. When it comes to a cancer diagnosis and treatment, every minute counts. According to ...
The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...
Morning Overview on MSN
1 protein block slowed cancer in mice, and it’s a promising target
Researchers have identified a single protein whose absence can cripple tumors in mice, slowing their growth and in some cases ...
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...
Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...
Sweeney won the Top Presentation Award for his talk titled, “The SUMO Balancing Act: Insights into Cellular Robustness from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results